Leflunomide for Henoch-Schonlein Purpura

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Henoch-Schonlein Purpura
Interventions
DRUG

Leflunomide

When patients appeared with rashes and treated with antibiotics, antihistamines, calcium supplements, and glucocorticoids (2 mg/kg/d) for 5 days. The rashes do not subside or fresh rash still appears, and it frequently repeats more than 3 times during hospitalization. Leflunomide would be administered

Trial Locations (1)

510120

RECRUITING

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER